Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis.

Víctor Granados-GarcíaYvonne N FloresLizbeth I Díaz-TrejoLucia Méndez-SánchezStephanie LiuGuillermo Salinas EscuderoFiliberto Toledano-ToledanoJorge Salmerón

Published in: PloS one (2019)

In this systematic review and meta-analysis, we found that the pooled prevalence of HCV was high (0.729) among a group of seven upper middle income countries. However, there was significant variation in the prevalence of HCV observed in China (0.633) and Brazil (0.396).

Keyphrases

risk factors
hepatitis c virus
physical activity
mental health
human immunodeficiency virus
randomized controlled trial
high dose
emergency department
phase iii
antiretroviral therapy